STOCKHOLM – September 20, 2016 – At ISUOG’s 26th World Congress on Ultrasound in Obstetrics and Gynecology next week in Rome, ContextVision, the leading provider of medical image processing software, will demonstrate its state of the art GOPiCE® 2.0 and REALiCE® 3D/4D ultrasound products. ContextVision’s ultrasound products are used globally by world-renowned OEMs; nearly 140,000 advanced ultrasound machines are equipped with ContextVision image processing software.
During the event, experienced ContextVision application specialists will be on site to discuss how these advanced products have helped clinicians across the world obtain the highest image quality for any application. Two products will be highlighted:
GOPiCE 2.0, the second generation of ContextVision’s unique 3D/4D image enhancement software, provides OEMs with the best ultrasound image quality available today. It is the only image enhancement product on the market for real-time 3D ultrasound.
REALiCE, ContextVision’s versatile visualization software presents fetuses in never-before-seen 3D/4D clarity. True-to-data rendering technology provides unique views of anatomies in early fetal diagnosis.
“OB/GYN applications are driving 3D and 4D developments in ultrasound. There is high clinical value,” said Fredrik Palm, vice president – OEM business, ContextVision. “ContextVision’s 3D/4D image enhancement and visualization offerings are the only in the world to provide true-to-data imaging, which gives more detailed information and supports clinicians in making accurate and fast diagnoses. We deliver the highest image quality within ultrasound to meet the growing demand from healthcare providers and offer customized solutions to optimize specific needs for every 3D/4D ultrasound systems.”
For more information or to see a product demonstration at ISUOG 2016, please visit ContextVision at booth 23B at ISUOG, or visit www.contextvision.com.
ContextVision is a medical technology company specializing in image analysis and artificial intelligence. Its cutting-edge technology helps doctors accurately interpret medical images, a crucial foundation for better diagnosis and treatment. An industry pioneer for more than 30 years, ContextVision is taking a leading position within deep learning, the latest artificial intelligence technology, and is investing significantly in the field to expand the company’s product portfolio. The present product portfolio includes state-of-the-art image enhancement software for 2D/3D/4D ultrasound, MRI, X-ray and mammography which is used by leading equipment manufacturers worldwide. ContextVision is based in Sweden and listed on the Oslo Stock Exchange under the ticker COV. For more information, please visit www.contextvision.com. Back to HCB News